Li-qin Tang

17# Lu Jiang Road
Hefei, 230001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Synergistic degradation of circular RNAs by RNAseK and lysosome.

Synergistic degradation of circular RNAs by RNAseK and lysosome.

Journal: Cell reports

Published: May 13, 2025

Fe-based nanozyme with photothermal activity prepared from polymerization-induced self-assembly assays boosts the recovery of bacteria-infected wounds.

Fe-based nanozyme with photothermal activity prepared from polymerization-induced self-assembly assays boosts the recovery of bacteria-infected wounds.

Journal: Acta biomaterialia

Published: July 29, 2024

ZC3H14 facilitates backsplicing by binding to exon-intron boundary and 3' UTR.

ZC3H14 facilitates backsplicing by binding to exon-intron boundary and 3' UTR.

Journal: Molecular cell

Published: February 20, 2024

Corrigendum: MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy.

Corrigendum: MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy.

Journal: Frontiers in cell and developmental biology

Published: February 14, 2022

Berberine regulates mesangial cell proliferation and cell cycle to attenuate diabetic nephropathy through the PI3K/Akt/AS160/GLUT1 signalling pathway.

Berberine regulates mesangial cell proliferation and cell cycle to attenuate diabetic nephropathy through the PI3K/Akt/AS160/GLUT1 signalling pathway.

Journal: Journal of cellular and molecular medicine

Published: August 14, 2021

MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy.

MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy.

Journal: Frontiers in cell and developmental biology

Published: October 17, 2020

Berberine ameliorates renal impairment and inhibits podocyte dysfunction by targeting the phosphatidylinositol 3-kinase-protein kinase B pathway in diabetic rats.

Berberine ameliorates renal impairment and inhibits podocyte dysfunction by targeting the phosphatidylinositol 3-kinase-protein kinase B pathway in diabetic rats.

Journal: Journal of diabetes investigation

Published: April 28, 2019

Berberine attenuates podocytes injury caused by exosomes derived from high glucose-induced mesangial cells through TGFβ1-PI3K/AKT pathway.

Berberine attenuates podocytes injury caused by exosomes derived from high glucose-induced mesangial cells through TGFβ1-PI3K/AKT pathway.

Journal: European journal of pharmacology

Published: December 28, 2017

Berberine exerts renoprotective effects by regulating the AGEs-RAGE signaling pathway in mesangial cells during diabetic nephropathy.

Berberine exerts renoprotective effects by regulating the AGEs-RAGE signaling pathway in mesangial cells during diabetic nephropathy.

Journal: Molecular and cellular endocrinology

Published: November 14, 2016

Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy.

Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy.

Journal: Pharmacological research

Published: July 21, 2016

G protein-coupled receptors: potential therapeutic targets for diabetic nephropathy.

G protein-coupled receptors: potential therapeutic targets for diabetic nephropathy.

Journal: Journal of receptor and signal transduction research

Published: December 18, 2015

Renoprotective effect of berberine via regulating the PGE2 -EP1-Gαq-Ca(2+) signalling pathway in glomerular mesangial cells of diabetic rats.

Renoprotective effect of berberine via regulating the PGE2 -EP1-Gαq-Ca(2+) signalling pathway in glomerular mesangial cells of diabetic rats.

Journal: Journal of cellular and molecular medicine

Published: November 01, 2015

Showing 1-12 of 19

Last Updated: 09/26/2026